PVP Ventures Limited has informed the Exchange about appointment of internal auditor
PVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PVP Ventures reported Q1 FY26 (June 2025) standalone revenue of Rs. 919.28 lakhs versus nil in Q1 FY25, turning profitable with a net profit of Rs. 78.19 lakhs against a loss of Rs. 138.64 lakhs last year. The board appointed BDO India LLP as internal auditor for FY25-26 and recommended M/s. ARS & Associates as secretarial auditors for five years. During the quarter, the company raised Rs. 15,000 lakhs via listed NCDs and completed two acquisitions — Optimus Oncology (56%) and Biohygea Global (52%) — which became subsidiaries effective April 30, 2025. Several legacy issues remain open: SEBI summons to the company, CEO, and MD over past related-party transactions; a Rs. 21,843.49 lakh loan outstanding from erstwhile subsidiary NCCPL; and Rs. 2,800 lakhs receivable from PHML, which has negative net worth. The company reported favorable court orders on prior GST and stamp-duty disputes.
Short-term stock reaction may be mixed: revenue turnaround and new subsidiaries are positives, but recurring SEBI scrutiny on the MD/CEO, large unprovided exposures to stressed related parties (NCCPL and PHML), negative other equity of Rs. (4,953.95) lakhs, and a sharp rise in finance costs signal ongoing risk for shareholders.